Real-time enrollment status for this bipolar depression clinical trial
Current Status
Active, Not Recruiting
Checked: June 2, 2026 at 2:37 AM UTC
| NCT Number | NCT06869187 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Bipolar Depression |
| Phase | Clinical Trial |
| Target Enrollment | 35 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Autobahn Therapeutics, Inc. |
| Last Updated on CT.gov | May 26, 2026 (1 week ago) |
As of June 2, 2026: Clinical trial NCT06869187 is currently active_not_recruiting participants. This clinical trial study for bipolar depression is not currently accepting new participants at 6 locations across the United States. The study is sponsored by Autobahn Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06869187 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06869187 was last updated 1 week ago (May 26, 2026). HelloStudys verifies this status automatically.